MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/hdi.13011

Медицинская библиотека · Hemodialysis international. International Symposium on Home Hemodialysis · 2022

Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.

Tung Kuei-Ting, Peng Yu-Sen, Hsu Shih-Ping, Wu Hon-Yen, Chiu Yen-Ling, Yang Ju-Yeh, Pai Mei-Fen, Shu Kai-Hsiang, Pan Szu-Yu, Lu Hui-Ming, Lin Wan-Yu, Liao Chun-Hsing, Chu Fang-Yeh, Tsai Wan-Chuan

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVES

The immunogenicity of vaccines is known to be attenuated in patients with end-stage kidney disease due to uremia. Patients on dialysis were excluded from coronavirus disease 2019 (COVID-19) vaccine trials; thus, the effectiveness of vaccines for this population is unclear. The aim of this study was to explore whether Asian dialysis patients can effectively produce an immune response after being vaccinated with the first dose of the ChAdOx1 nCoV-19 vaccine.

DESIGN SETTING, PARTICIPANTS, AND MEASUREMENTS: In this prospective cohort study, we included Asian hemodialysis patients who received the ChAdOx1 nCoV-19 vaccine. At 3 weeks after the first dose of vaccination, we assessed the humoral immune response by measuring anti-SARS-CoV-2 S antibody titers. The primary outcome was the seropositive rate following vaccination, defined as an antibody titer greater than or equal to 0.8 U/ml. Factors associated with seropositivity were explored in multivariate logistic regression analyses.

RESULTS

In total, 434 participants were included. The mean age was 64 years, the mean dialysis vintage was 6 years, and 61% of the participants were men. At a mean time of 22 days from vaccination, 56% of the participants were seropositive. The vast majority (88%) had low antibody titers (< 15 U/ml). The multivariate logistic regression analyses showed that older age (every increase of 10 years, odds ratio [OR] 0.80, 95% CI 0.65-0.98, p = 0.03) was negatively associated with seropositivity and that higher Kt/V (every increase of 0.1, OR 1.14, 95% CI 1.01-1.28, p = 0.03) and higher serum albumin level (every increase of 0.1 g/dl, OR 1.09, 95% CI 1.02-1.18, p = 0.02) were positively associated with seropositivity.

CONCLUSIONS

In Asian hemodialysis patients, the seropositive rate was low, and most had low antibody titers after the first dose of the ChAdOx1 nCoV-19 vaccine. Younger age, better dialysis adequacy, and higher albumin levels were associated with seropositivity.

Для цитирования: Tung Kuei-Ting, Peng Yu-Sen, Hsu Shih-Ping, Wu Hon-Yen, Chiu Yen-Ling, Yang Ju-Yeh, Pai Mei-Fen, Shu Kai-Hsiang, Pan Szu-Yu, Lu Hui-Ming, Lin Wan-Yu, Liao Chun-Hsing, Chu Fang-Yeh, Tsai Wan-Chuan. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.. Hemodialysis international. International Symposium on Home Hemodialysis. 2022. DOI: 10.1111/hdi.13011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.